Why is Senores Pharma. falling/rising?

As of 19-Sep, Senores Pharmaceuticals Ltd is currently priced at 713.00, reflecting a decrease of 2.9, or 0.41%. The stock has recently underperformed its sector by 0.68% and has experienced a trend reversal, falling after two consecutive days of gains. Despite this decline, the stock has shown positive performance over the past week and month, with returns of 3.51% and 1.88%, respectively. The company has demonstrated strong fundamentals, including a low debt-to-equity ratio and impressive growth in net sales and operating profit. However, it faces challenges with a high price-to-book value and a relatively low return on equity, which may contribute to its recent price movement.
In the broader market context, Senores Pharmaceuticals has outperformed the Sensex over the past week and month, indicating a stronger short-term return compared to the benchmark. However, the stock's performance over the past year has been flat, generating a return of 0.00%, while institutional investors have decreased their stake, suggesting a lack of confidence from more sophisticated market participants. This decline in institutional participation could be influencing the stock's recent downward movement, despite its solid operational metrics and rising investor participation in terms of delivery volume.